Lemtrada (alemtuzumab) Sanofi Genzyme Deaths

A pharmacetical company in the USA is selling a drug which costs $158,000 per treatment per person and was approved by the FDA although it states on the FDA website the drug can cause fatalities. (FDA PDF Below). It has been used in the UK since 2016. Lemtrada Targets MS-related Cells Lemtrada, which is also … Continue reading Lemtrada (alemtuzumab) Sanofi Genzyme Deaths